Searched for
ASTRAZENECA NEWS
India a major growth market for Celonis, says senior execThe Germany-based company said it already serves 260 global capability centres (GCCs) in India, counting companies such as Mercedes-Benz, H...- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...
- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
- China detains AstraZeneca staff in data, drug-import probes: Report"We are aware a small number of our employees in China are under investigation and we have no further information to share at this point," ...
- AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
- AstraZeneca to seek US approval of COVID vaccine in 2nd halfThe Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its s...
- EU regulator advices against second AstraZeneca shot in those with blood clotsThe advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...
- EU sues AstraZeneca over delayed deliveries of COVID-19 vaccine"AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. ...
- Australia shares end lower as vaccine rollout hits snagThe S&P/ASX 200 index settled 0.1 per cent lower at 6,995.2 points at close of trade, applying brakes on its longest winning run since earl...
- France to recommend mRNA COVID-19 shots as second dose for some after AstraZeneca: MinisterConfidence in the AstraZeneca vaccine has dropped in Europe since a very few, mostly young, recipients of the shot were found to have suffe...
- UK PM Boris Johnson says he will get Oxford/AstraZeneca COVID-19 vaccine very soonBritish Prime Minister Boris Johnson said on Wednesday he would get the Oxford/AstraZeneca COVID-19 shot very soon, voicing his confidence ...
- Canada sure all that COVID-19 vaccines are safe, including AstraZeneca doses: PMCanadian health experts are sure all COVID-19 vaccines being administered in the country are safe, including those made by AstraZeneca PLC,...
- 2020's parting shot: India to roll out COVID-19 vaccine in January"India is a part of 'COVAX'. We will keep giving 50 per cent of everything we make to India and to COVAX at the same time. India has such a...
- No reason to worry about Oxford-AstraZeneca vaccine, says UK minister"I don't think there is any reason to be unduly concerned," British housing minister Robert Jenrick told Sky News. "We have now written to ...
- 'Really good news': British Health Secretary Matt Hancock welcomes Oxford/AstraZeneca vaccine results"These figures ... shows that the vaccine in the right dosage can be up to 90% effective," British Health Secretary Matt Hancock told Sky N...
- AstraZeneca plunges 13% as Covid-19 drug trial put on holdAstraZeneca began its Phase 3 trial in the US in late August. The US trial was currently taking place at 62 sites across the country.
- Good news on Oxford, AstraZeneca's coronavirus vaccine could come on Thursday: ReportHEALTH-CORONAVIRUS-OXFORD-VACCINE-Positive news on Oxford/AstraZeneca COVID-19 vaccine could come Thursday: report
- Dr Reddy's trades steady, shrugs off legal challengeDRL’s generic version was to be marketed as Ticaflo, according to those in the know.
- AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...
Load More
